Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor

Detalles Bibliográficos
Autores principales: Hu, Zexi, Hu, Yong, Liu, Xicheng, Xi, Rongwen, Zhang, Aiqun, Liu, Deruo, Xie, Qiang, Chen, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219658/
https://www.ncbi.nlm.nih.gov/pubmed/30443295
http://dx.doi.org/10.18632/oncotarget.26252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219658/
https://www.ncbi.nlm.nih.gov/pubmed/30443295
http://dx.doi.org/10.18632/oncotarget.26252

Ejemplares similares